NCT07687979 Mobile Application for Gait Training in Parkinson's Disease
| NCT ID | NCT07687979 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ege University |
| Condition | PARKINSON DIS |
| Study Type | INTERVENTIONAL |
| Enrollment | 52 participants |
| Start Date | 2026-04-07 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 52 participants in total. It began in 2026-04-07 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The developed mobile application provides patient-specific metronome-based auditory cues and simultaneous tactile vibrations to regulate walking rhythm. In this study, the effects of the mobile application on walking performance and balance in patients with Parkinson's disease will be examined in a single-center, controlled design. Participants will undergo gait training for 30 minutes per day, 3 days a week, for a total of 6 weeks. The experimental group will use the mobile application, while the control group will receive standard gait training without any external stimuli. Walking and functional performance will be assessed before and after the intervention using the Timed Up and Go Test (TUG) to assess functional mobility and dynamic balance, the 5-Times Sit to Stand Test (5xSST) to evaluate lower extremity functional strength, and the Freezing of Gait Questionnaire (FOGQ) to evaluate freezing episodes. Additionally, spatiotemporal walking parameters will be measured using a separate gait analysis mobile application. Appropriate statistical tests will be applied, and a significance level of p\<0.05 will be considered.
Eligibility Criteria
Inclusion Criteria: Diagnosed with idiopathic Parkinson's disease by a neurologist based on clinical and radiological findings. Disease severity between stages 1 to 3 according to the Modified Hoehn and Yahr Scale. Able to walk at least 10 meters independently or with an assistive device. Being in the "ON" period of Parkinson's medication. Ability to use technological devices such as smartphones (scoring 35 or higher on the Digital Competence Inventory for Older Adults). Fluent in reading, understanding, and speaking Turkish. Voluntarily participating in the study. Exclusion Criteria: Having neurological disorders other than Parkinson's disease that could affect mobility. History of knee joint surgery or traumatic injury affecting the knee joint. History of any surgery within the last 6 months. Presence of a deep brain stimulator. Hearing impairment. Cognitive impairment or inability to understand and follow the study procedures. Other physical or systemic conditions that could affect walking assessments (e.g., amputation, severe diabetes mellitus, alcohol addiction).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07687979 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, up to 80 Years, studying PARKINSON DIS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07687979 currently recruiting?
Yes, NCT07687979 is actively recruiting participants. Contact the research team at mehmet.ozkeskin76@gmail.com for enrollment information.
Where is the NCT07687979 trial being conducted?
This trial is being conducted at Izmir, Turkey (Türkiye).
Who is sponsoring the NCT07687979 clinical trial?
NCT07687979 is sponsored by Ege University. The trial plans to enroll 52 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.